Serotonin antagonist: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Serotonin antagonist": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
| Line 1: | Line 1: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 13: | Line 13: | ||
{{Receptor agonists and antagonists}} | {{Receptor agonists and antagonists}} | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 15:59, 20 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A serotonin antagonist acts to inhibit the action at serotonin receptors.
Many of the most important medications of this class selectively act at the 5-HT3 receptor, and thus are known as 5-HT3 antagonists. However, other drugs such as ketanserin act upon other types of serotonin receptors.
External links
- Serotonin+Antagonists at the US National Library of Medicine Medical Subject Headings (MeSH)